INPP4B and cancer: Since gene expression-based biomarkers may offer a rapid and cost effective method for risk stratification, we assessed whether INPP4B gene expression is associated with patient outcome across many cancers by applying CoxPH SubID to INPP4B gene expression and clinical data from 25 cancer datasets from TCGA (Table 1, S1 Table).